NanoViricides, Inc. (NNVC)
1.34
+0.04
(+3.08%)
USD |
NYAM |
Jun 26, 16:00
1.33
-0.01
(-0.75%)
After-Hours: 20:00
NanoViricides Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | -0.0843M |
| June 30, 2025 | -0.0102M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | -0.0468M |
| June 30, 2024 | -0.0982M |
| March 31, 2024 | -0.0446M |
| December 31, 2023 | -0.0055M |
| September 30, 2023 | -0.0083M |
| June 30, 2023 | -0.0026M |
| March 31, 2023 | -0.0593M |
| December 31, 2022 | -0.0453M |
| September 30, 2022 | -0.0445M |
| June 30, 2022 | -0.0754M |
| March 31, 2022 | -0.0393M |
| December 31, 2021 | -0.1853M |
| September 30, 2021 | -0.0243M |
| June 30, 2021 | -0.0846M |
| March 31, 2021 | -0.1106M |
| December 31, 2020 | -0.0086M |
| September 30, 2020 | -0.035M |
| June 30, 2020 | -0.0045M |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.0041M |
| June 30, 2019 | -0.0097M |
| March 31, 2019 | -0.0066M |
| December 31, 2018 | -0.0203M |
| September 30, 2018 | -0.0373M |
| June 30, 2018 | -0.0166M |
| March 31, 2018 | -0.1327M |
| December 31, 2017 | -0.0621M |
| September 30, 2017 | -0.0304M |
| June 30, 2017 | -0.0464M |
| March 31, 2017 | -0.0942M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.0244M |
| June 30, 2016 | -0.0521M |
| March 31, 2016 | -0.0608M |
| December 31, 2015 | -0.0298M |
| September 30, 2015 | -0.3337M |
| June 30, 2015 | -1.196M |
| March 31, 2015 | 0.7492M |
| December 31, 2014 | -4.751M |
| September 30, 2014 | -0.5625M |
| June 30, 2014 | -0.6129M |
| March 31, 2014 | -1.260M |
| December 31, 2013 | -0.084M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Soligenix, Inc. | 0.00 |
| Pyxis Oncology, Inc. | 16.37M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Anika Therapeutics, Inc. | -1.239M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.931M |
| Cash from Financing (Quarterly) | -0.0067M |
| Free Cash Flow | -7.370M |
| Free Cash Flow Per Share (Quarterly) | -0.0893 |
| Free Cash Flow to Equity (Quarterly) | -1.931M |
| Free Cash Flow to Firm (Quarterly) | -1.931M |
| Free Cash Flow Yield | -29.31% |